Home > Insider Trading > Coherus Oncology Inc.

Coherus Oncology Inc. (CHRS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Third Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

November 7th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q2 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Second Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

August 4th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Q1 2023 Earnings Call. Please be advised that today’s conference is being recorded.

Keep Reading →

May 10th, 2023 - News Transcripts

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2022 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to Coherus Biosciences Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.

Keep Reading →

March 8th, 2023 - News Transcripts

Should You Invest in Coherus BioSciences (CHRS)?

Scout Investments, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” third quarter 2022 investor letter.

Keep Reading →

January 3rd, 2023 - Hedge Fund Investor Letters News

Will Coherus BioSciences (CHRS) Stock Bounce Back?

Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 10th, 2022 - Hedge Fund Investor Letters News

10 Biotech Stocks to Buy Today According to Kerr Neilson's Platinum Asset Management

In this piece, we will take a look at the ten biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management. If you want to skip the details about Mr.

Keep Reading →

April 20th, 2022 - Hedge Funds News

10 Best Healthcare Stocks Under $20 According to Michael Castor's Sio Capital

In this article, we discuss the 10 best healthcare stocks under $20 according to Michael Castor's Sio Capital.

Keep Reading →

September 28th, 2021 - Hedge Funds News

Hedge Funds Are Warming Up To Coherus Biosciences Inc (CHRS)

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...

Keep Reading →

July 19th, 2021 - Hedge Funds News

Hedge Funds Are Selling Coherus Biosciences Inc (CHRS)

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Keep Reading →

September 28th, 2020 - Hedge Funds News